We act as a highly experienced resource for oncology outcomes and real-world evidence (RWE) queries from research collaborators and industry partners in order to ensure the quality and integrity of results and to accelerate the transformation of projects into clinical practice and policy impact.
O2 Difference
Breadth of Data
- Strategic analysis of target oncology populations across the healthcare spectrum within both academic and community cancer centers (i.e. a population-based approach)
- HEOR focus with in-depth and comprehensive aggregate ‘events’ and outcomes analysis that can accurately inform pharmaco-economic modelling of cancer therapeutics
Real-World Inspiration
- Meaningful analysis of real-world data that is tailored to support data and evidence gaps in unique oncology groups and specific therapeutics markets
- Advanced statistics to quantify a cancer population’s treatment and survival outcomes
R2:
Rapid Results
- Rapid results and short project turnaround time
- Standardized reporting of aggregate results across a spectrum of cancer disease sites
- Advanced analytics to highlight the unmet need within target oncology populations
Why RWE and Why Now?
The Evidence Gap
Who We Work With
